Epilepsy and Child and Adolescent Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Epilepsia. 2012 Dec;53(12):2164-71. doi: 10.1111/j.1528-1167.2012.03661.x. Epub 2012 Sep 18.
Epilepsy is a common childhood neurologic disorder, affecting 0.5-1% of children. Increased mortality occurs due to progression of underlying disease, seizure-related accidents, suicide, status epilepticus, aspiration during seizures, and sudden unexplained death in epilepsy (SUDEP). Previous studies show mortality rates of 2.7-6.9 per 1,000 person-years. Potential risk factors include poor seizure control, intractable epilepsy, status epilepticus, tonic-clonic seizures, mental retardation, and remote symptomatic cause of epilepsy. Few population-based studies of mortality and SUDEP in childhood-onset epilepsy have been published. The purpose of this study is to report mortality and SUDEP from a 30-year population-based cohort of children with epilepsy.
The Medical Diagnostic Index of the Rochester Epidemiology Project was searched for all codes related to seizure and convulsion in children living in Olmsted County, Minnesota and of ages birth through 17 years from 1980 through 2009. The medical records of these children were reviewed to identify all those with new-onset epilepsy, and to abstract other baseline and follow-up information. Potential risk factors including seizure type, epilepsy syndrome, history of status epilepticus, the presence and severity of neurologic impairment, and epilepsy outcome was reviewed. Epilepsy outcome was characterized by seizure frequency, number of antiseizure medications (antiepileptic drugs, AEDs) used, and number of AEDs failed due to lack of efficacy, and epilepsy intractability at 1 year and 2, 3, 5, 10, 15, and 20 years after epilepsy onset. We followed all children through their most recent visit to determine vital status, cause of death, and whether autopsy was performed.
From 1980 to 2009, there were 467 children age birth through 17 years diagnosed with epilepsy while residents of Olmsted County, Minnesota, and who had follow-up beyond the time of epilepsy diagnosis. Children were followed for a median of 7.87 years after the time of diagnosis (range 0.04-29.49 years) for a total of 4558.5 person-years. Sixteen (3.4%) of the children died, or 3.51 deaths per 1,000 person-years. Two deaths were epilepsy related (12.5%) for a rate of 0.44 per 1,000 person-years. One of these children died of probable SUDEP and one died of aspiration during a seizure. The remaining 14 deaths (87.5%) were caused by other complications of underlying disease. Several risk factors for mortality were found, including abnormal cognition, abnormal neurologic examination, structural/metabolic etiology for epilepsy, and poorly controlled epilepsy.
Although mortality in children with epilepsy was higher than what would be expected in the general pediatric population, death occurred significantly more in children with neurologic impairment and poorly controlled epilepsy. Epilepsy-related death, including SUDEP, was rare and mortality due to epilepsy alone was similar to the expected mortality in the general population (observed deaths = 2, expected deaths = 1.77; standardized mortality ratio 1.13, 95% confidence interval 0.19-3.73, p = 0.86). By contrast, most children died of complications of the underlying neurologic disease or unrelated disease rather than the epilepsy.
癫痫是一种常见的儿童神经系统疾病,影响 0.5-1%的儿童。由于基础疾病的进展、与癫痫发作相关的意外、自杀、癫痫持续状态、癫痫发作时的吸入以及癫痫猝死(SUDEP),死亡率增加。先前的研究表明,每 1000 人年的死亡率为 2.7-6.9。潜在的危险因素包括癫痫控制不佳、难治性癫痫、癫痫持续状态、强直阵挛性发作、智力迟钝和癫痫的远程症状性病因。发表的关于儿童期起病癫痫的死亡率和 SUDEP 的人群研究较少。本研究的目的是报告来自明尼苏达州奥姆斯特德县一个 30 年的儿童癫痫患者的人群队列的死亡率和 SUDEP。
罗切斯特流行病学项目的医疗诊断索引被搜索以确定所有与儿童癫痫发作和惊厥相关的代码,这些儿童居住在明尼苏达州奥姆斯特德县,年龄在出生至 17 岁之间,时间从 1980 年至 2009 年。对这些儿童的医疗记录进行了审查,以确定所有新发癫痫的儿童,并提取其他基线和随访信息。审查了潜在的危险因素,包括癫痫发作类型、癫痫综合征、癫痫持续状态史、存在和严重程度的神经功能障碍以及癫痫的结局。癫痫的结局特征是癫痫发作频率、抗癫痫药物(抗癫痫药,AEDs)的使用数量、由于缺乏疗效而导致的 AED 失败数量,以及在癫痫发作后 1 年、2 年、3 年、5 年、10 年、15 年和 20 年的癫痫发作的治疗效果。我们对所有儿童进行随访,直到他们最近一次就诊,以确定他们的生存状态、死亡原因以及是否进行了尸检。
1980 年至 2009 年期间,明尼苏达州奥姆斯特德县有 467 名年龄在出生至 17 岁之间的儿童被诊断患有癫痫,且在癫痫诊断后进行了随访。儿童在诊断后中位随访 7.87 年(范围 0.04-29.49 年),共随访 4558.5 人年。16 名(3.4%)儿童死亡,即每 1000 人年死亡 3.51 人。其中 2 例死亡与癫痫有关(12.5%),即每 1000 人年死亡 0.44 人。其中一名儿童死于可能的 SUDEP,另一名死于癫痫发作时的吸入。其余 14 例死亡(87.5%)是由潜在疾病的其他并发症引起的。发现了几个与死亡率相关的危险因素,包括认知异常、神经检查异常、癫痫的结构/代谢病因以及癫痫控制不佳。
尽管癫痫儿童的死亡率高于儿科人群的预期,但患有神经功能障碍和癫痫控制不佳的儿童死亡率明显更高。癫痫相关死亡,包括 SUDEP,较为罕见,癫痫相关死亡单独的死亡率与普通人群的预期死亡率相似(观察到的死亡人数=2,预期死亡人数=1.77;标准化死亡率比 1.13,95%置信区间 0.19-3.73,p=0.86)。相比之下,大多数儿童死于潜在神经疾病或无关疾病的并发症,而不是癫痫。